Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
ASY15905LEMTRADA-ITPNCT03784898Tabulated Results
ALEMTUZUMAB
Campath
Leukemia
CAM203NANCT00328198Tabulated Results
ALEMTUZUMAB
Campath
Leukemia
CAM211*NASummary
ALEMTUZUMAB
Campath
Leukemia
CAM307*NANCT00046683Summary
ALEMTUZUMAB
Campath
Leukemia
CAM314NANCT00086580Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
CAMMS03409CARE-MS IINCT00548405Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
CAMMS223NANCT00050778Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
CAMMS323CARE-MS INCT00530348Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
CAMMS32400507CARE-MS IINCT00548405Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
LPS13649TOPAZNCT02255656Tabulated Results

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted